1. Home
  2. CPAC vs URGN Comparison

CPAC vs URGN Comparison

Compare CPAC & URGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cementos Pacasmayo S.A.A. (Each representing five)

CPAC

Cementos Pacasmayo S.A.A. (Each representing five)

HOLD

Current Price

$12.17

Market Cap

1.0B

Sector

Industrials

ML Signal

HOLD

Logo UroGen Pharma Ltd.

URGN

UroGen Pharma Ltd.

HOLD

Current Price

$41.34

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPAC
URGN
Founded
1949
2004
Country
Peru
United States
Employees
N/A
N/A
Industry
Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
2.2B
IPO Year
2003
2016

Fundamental Metrics

Financial Performance
Metric
CPAC
URGN
Price
$12.17
$41.34
Analyst Decision
Hold
Strong Buy
Analyst Count
2
7
Target Price
$12.90
★ $29.29
AVG Volume (30 Days)
43.1K
★ 597.6K
Earning Date
04-24-2026
05-06-2026
Dividend Yield
★ 5.23%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $1,128,000.00
Revenue This Year
$4.49
$129.09
Revenue Next Year
N/A
$70.96
P/E Ratio
$19.78
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$6.25
$15.86
52 Week High
$12.74
$50.81

Technical Indicators

Market Signals
Indicator
CPAC
URGN
Relative Strength Index (RSI) 46.56 41.02
Support Level $12.10 $18.25
Resistance Level $12.38 $44.63
Average True Range (ATR) 0.19 2.01
MACD -0.06 -0.28
Stochastic Oscillator 15.62 23.16

Price Performance

Historical Comparison
CPAC
URGN

About CPAC Cementos Pacasmayo S.A.A. (Each representing five)

Cementos Pacasmayo SAA is a Peruvian cement company, and only cement manufacturer serving in the northern region of Peru. It produce, distribute and sell cement and cement-related materials, such as precast products and ready-mix concrete. Its products are mainly used in construction, which has been one of the fastest growing segments of the Peruvian economy in recent years. It also produce and sell quicklime for use in mining operations. It also provide transportation services. It has three operating segments cement, concrete, mortar, pavement and precast; quicklime; and sales of construction supplies. The majority of profit comes from Cement segment. Peru's cement production is into three regions northern region, central region, including Lima's metropolitan area, and southern region.

About URGN UroGen Pharma Ltd.

UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. The company's flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with Zusduri (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. The revenue source for the company comes from sales of the Company's approved products, Jelmyto and Zusduri, principally conducted in the United States.

Share on Social Networks: